Owlet, Inc. (OWLT) Stock

Owlet, Inc. (OWLT) is a Technology stock trading at $5.61 (as of 2026-08-20), with a market capitalization of $162.55M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Owlet, Inc. offers products for families’ infant monitoring and sleep support in the United States, including a wearable sock system that tracks vital signs and sleep, along with video monitoring and companion software. Its offerings are used by parents and caregivers to monitor babies and support healthy sleep routines.

Understand Owlet, Inc.: how it makes money

Owlet sells connected baby-monitoring products and companion apps, including the Smart Sock wearable and video sleep tools, and it makes money through related product sales and ongoing subscription-style engagement tied to its platform.

Owlet's path to better profitability depends on its ability to turn wearable hardware users into recurring, stickier platform usage, since operating performance will be constrained if subscription penetration and retention do not grow enough to offset the costs of operating the platform.

Revenue by segment (latest quarter)
NetRev$0.0B

Business quality (Weak): The company has measurable user engagement and subscription-related metrics (attach rates, retention, and NPS), but profitability is currently weak (negative operating margin), so investors should focus on whether recurring revenue engagement can scale with the installed base.

Bull case

  • High early engagement and stickiness signals: Owlet 360 Retention Rate After First Month is 85.0 percent, and Owlet 360 Daily Active User Rate is 60.0 percent.
  • Subscription conversion exists: DreamSock Subscription Attach Rate is 25.0 percent, and DreamSock Net Promoter Score is 77.0.
  • Positive customer sentiment for the broader offering: DreamSoc Net Promoter Score is 73.0, and Blended Product Net Promoter Score is 71.0.

Bear case

  • Current profitability is negative: The latest quarter shows an operating margin of -24.5 percent, even with a gross margin of 54.5 percent.
  • Low reported revenue in the period: The provided quarter revenue figure is 0.0B (with segment net revenue candidate of 0.02B), which may limit the ability to cover fixed costs.
  • Ongoing device-to-subscription scaling is uncertain: Key subscription penetration metrics are not yet overwhelming, for example Subscription Penetration Rate for DreamSock Users is 34.0 percent, so further growth may be required for operating leverage.
Valuation — source: SEC EDGAR (first-party)
Price$5.61
Market Cap$162.55M
Price / Book7.03
Price / Sales0.88
FCF Yield-9.7%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$105.71M
Net Margin-37.5%
Revenue Growth (YoY)35.4%
EPS Growth (YoY)47.1%
FCF Growth (YoY)-1.6%
Financial Health — source: SEC EDGAR
Altman Z-Score-2.17 (distress)
Valuation vs Sector & Industry
Sector P/E (Technology)33.9
Industry P/E (Measuring & Control Equipment)51.8
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderECLIPSE OPERATIONS, LLC ($39.58M)
Institutional Holders Tracked10
Company
SectorTechnology
IndustryMeasuring & Control Equipment
CEOJonathan Harris
Employees80
CountryUS
IPO Date2020-11-05

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • 908 Devices Inc. (MASS)
  • Harvard Bioscience, Inc. (HBIO)
  • Quantum-Si incorporated (QSI)
  • Quanterix Corporation (QTRX)
  • Nautilus Biotechnology, Inc. (NAUT)
  • Seer, Inc. (SEER)
  • Geospace Technologies Corporation (GEOS)
  • Birchtech Corp. (BCHT)
OWLT earnings history · OWLT institutional & insider holders · OWLT KPIs & operating metrics · OWLT financials · OWLT investor presentations & press releases · OWLT SEC filings · OWLT peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.